Key to a cheaper and more accessible Hib vaccine found

Copyright: Julia Schulze (left), Dr. Timm Fiebig and Andrea Bethe have deciphere
Copyright: Julia Schulze (left), Dr. Timm Fiebig and Andrea Bethe have deciphered the pathway of the bacterial capsule of Haemophilus influenzae type b (Hib). Copyright: Karin Kaiser / MHH
Copyright: Julia Schulze ( left ), Dr. Timm Fiebig and Andrea Bethe have deciphered the pathway of the bacterial capsule of Haemophilus influenzae type b (Hib). Copyright: Karin Kaiser / MHH The bacterium Haemophilus influenzae type b (Hib) can cause severe meningitis in young children. Our researchers now have a way to make the Hib vaccine cheaply and more easily. The bacterium Haemophilus influenzae type b (Hib) can cause severe diseases such as meningitis and blood poisoning in young children. Researchers from the MHH Institute of Clinical Biochemistry have deciphered the pathway of the bacterial capsule and thus created the basis for producing the Hib vaccine inexpensive and safe. The bacterium Haemophilus influenzae type b (Hib) inhabits the human nasal cavity. It causes infections of the upper and lower respiratory tract, especially in infants and young children.
account creation

TO READ THIS ARTICLE, CREATE YOUR ACCOUNT

And extend your reading, free of charge and with no commitment.



Your Benefits

  • Access to all content
  • Receive newsmails for news and jobs
  • Post ads

myScience